Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

Implementing AI in regulated industries like healthcare requires more than advanced technology. It demands strategic ...

Alzheimer’s disease has rightly been characterised as a ‘silent pandemic’, with the number of Americans over 65 who are ...

AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn ...

As co-heads of the Communiqué Awards judging panel for the Action on Workplace DEI category, I spoke to Avril Lee, Chair of ...

Khan most recently served as executive vice president, head of commercial development at Complete HealthVizion ...

With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience ...

The UK government has published its 10 Year Health Plan for England, which will see millions of patients be treated and cared ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be approved in combination with ...

Inizio Evoke has announced the appointment of Kelly Cusumano as its first executive vice president, growth and client ...

The company formerly known as BeiGene announced that the Committee for Medicinal Products for Human Use (CHMP) has ...

All attendees shared a vested interest in the rapidly evolving cancer treatment landscape. Nowhere was the vastness of that ...